1.0Orbitalhttps://www.orbital-itn.euhammadhttps://www.orbital-itn.eu/author/hammad/rich600338<blockquote class="wp-embedded-content"><a href="https://www.orbital-itn.eu/projects/project-13-development-of-ex-vivo-models-for-smart-screening-of-novel-colloidal-ocular-formulations/">Project 13: Development of ex-vivo models for smart screening of novel colloidal ocular formulations</a></blockquote> <script type='text/javascript'> <!--//--><![CDATA[//><!-- /*! This file is auto-generated */ !function(d,l){"use strict";var e=!1,o=!1;if(l.querySelector)if(d.addEventListener)e=!0;if(d.wp=d.wp||{},!d.wp.receiveEmbedMessage)if(d.wp.receiveEmbedMessage=function(e){var t=e.data;if(t)if(t.secret||t.message||t.value)if(!/[^a-zA-Z0-9]/.test(t.secret)){var r,a,i,s,n,o=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),c=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]');for(r=0;r<c.length;r++)c[r].style.display="none";for(r=0;r<o.length;r++)if(a=o[r],e.source===a.contentWindow){if(a.removeAttribute("style"),"height"===t.message){if(1e3<(i=parseInt(t.value,10)))i=1e3;else if(~~i<200)i=200;a.height=i}if("link"===t.message)if(s=l.createElement("a"),n=l.createElement("a"),s.href=a.getAttribute("src"),n.href=t.value,n.host===s.host)if(l.activeElement===a)d.top.location.href=t.value}}},e)d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",t,!1),d.addEventListener("load",t,!1);function t(){if(!o){o=!0;var e,t,r,a,i=-1!==navigator.appVersion.indexOf("MSIE 10"),s=!!navigator.userAgent.match(/Trident.*rv:11\./),n=l.querySelectorAll("iframe.wp-embedded-content");for(t=0;t<n.length;t++){if(!(r=n[t]).getAttribute("data-secret"))a=Math.random().toString(36).substr(2,10),r.src+="#?secret="+a,r.setAttribute("data-secret",a);if(i||s)(e=r.cloneNode(!0)).removeAttribute("security"),r.parentNode.replaceChild(e,r)}}}}(window,document); //--><!]]> </script><iframe sandbox="allow-scripts" security="restricted" src="https://www.orbital-itn.eu/projects/project-13-development-of-ex-vivo-models-for-smart-screening-of-novel-colloidal-ocular-formulations/embed/" width="600" height="338" title="“Project 13: Development of ex-vivo models for smart screening of novel colloidal ocular formulations” — Orbital" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe>https://www.orbital-itn.eu/app/uploads/2020/04/NAV.jpg500273The topical treatment of eye diseases shows great advantages such as ease of administration, good patient compliance and cost effectiveness, but it still has drawbacks in great loss of drug and low bioavailability in deeper ocular tissues. Nanomedicine has great potential for the improvement of ocular administration: size of carriers and their surface characteristics are … Read More